View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure DAPAgliflozin and Effect on Cardiovascular Events in ACuTe Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
Location: CPMC (San Francisco)
Please contact: Milena Ferreira email@example.com about study DAPA
Interpretable Deep Learning Model for Longitudinal Electronic Health Record and Applications to Heart Failure Prediction
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator
Heart Failure Prevention "2 of 3 Study".
Investigators: Francisco Prieto, MD, Andrew Hudnut, MD, Craig Ruggles, M.D.
Interagency Registry for Mechanically Assisted Circulatory Support
Investigator: Robert Kincade, M.D., FACS